Invenra Invenra is a company focused on developing biologics with an emphasis on multispecific antibodies and their derivatives. | Stelvio Oncology Stelvio Oncology is a company that develops predictive diagnostics and therapeutics for malignant glioblastoma multiforme. | ![]() Bioprinting Laboratories Bioprinting Laboratories (BPL) is a company that develops disposable pillar/perfusion plates and bioprinted human mini-tissues derived from pluripotent stem cells. | ![]() Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | ||
Founding Date | Founding Date 2004 | Founding Date 2011 | Founding Date 2017 | Founding Date 2017 | Founding Date 1999 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Bethlehem, US HQ | Locations Madison, US HQ | Locations HQ | Locations Dallas, US HQ | Locations Marseille, FR HQ Rockville, US |
Employees | Employees 244% decrease | Employees 582% increase | Employees 1 | Employees 6 | Employees 181 |
Funding | |||||
Latest funding round | Latest funding round $ 22.4m (about 13 years ago) | Latest funding round $ 7.1m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 54.8m | Total funding raised $ 22m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 94.1m |
Invenra is a company focused on developing biologics with an emphasis on multispecific antibodies and their derivatives.
View companyStelvio Oncology is a company that develops predictive diagnostics and therapeutics for malignant glioblastoma multiforme.
View company
Bioprinting Laboratories (BPL) is a company that develops disposable pillar/perfusion plates and bioprinted human mini-tissues derived from pluripotent stem cells.
View company
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company